FOXO1 locus and acetylcholinesterase inhibitors in elderly patients with Alzheimer’s disease

References

• Alzheimer’s Disease Education Referral Center [homepage on the Internet]Bethesda, MDNational Institute on Aging2014 Available from: http://www.nia.nih.gov/alzheimersAccessed March 1, 2014
   Google Scholar
• alz.org [homepage on the Internet]Chicago, ILAlzheimer’s Association2014 Available from: http://www.alz.orgAccessed March 1, 2014
   Google Scholar
• HampelHPrvulovicDTeipelSThe future of Alzheimer’s disease: the next 10 yearsProg Neurobiol20119571872822137045
   PubMed Web of Science ®Google Scholar
• ImbimboBPPanzaFFrisardiVTherapeutic intervention for Alzheimer’s disease with γ-secretase inhibitors: still a viable option?Expert Opin Investig Drugs201120325341
   PubMed Web of Science ®Google Scholar
• PanzaFFrisardiVImbimboBPSeripaDSolfrizziVPilottoAMonoclonal antibodies against β-amyloid (Aβ) for the treatment of Alzheimer’s disease: the Aβ target at a crossroadsExpert Opin Biol Ther20111167968621501112
   PubMed Web of Science ®Google Scholar
• BirksJCholinesterase inhibitors for Alzheimer’s diseaseCochrane Database Syst Rev20061CD00559316437532
   PubMed Web of Science ®Google Scholar
• AtriAEffective pharmacological management of Alzheimer’s diseaseAm J Manag Care201117suppl 13S346S35522214392
   PubMedGoogle Scholar
• PilottoAFranceschiMD’OnofrioGEffect of a CYP2D6 polymorphism on the efficacy of donepezil in patients with Alzheimer diseaseNeurology20097376176719738170
   PubMed Web of Science ®Google Scholar
• AlbaniDBoneschiFMBiellaGReplication study to confirm the role of CYP2D6 polymorphism rs1080985 on donepezil efficacy in Alzheimer’s disease patientsJ Alzheimers Dis201230474574922465999
   PubMed Web of Science ®Google Scholar
• SeripaDBizzarroAPilottoARole of cytochrome P4502D6 functional polymorphisms in the efficacy of donepezil in patients with Alzheimer’s diseasePharmacogenet Genomics20112122523020859244
   PubMed Web of Science ®Google Scholar
• von BernhardiREugenínJAlzheimer’s disease: redox dysregulation as a common denominator for diverse pathogenic mechanismsAntioxid Redox Signal201216974103122122400
   PubMed Web of Science ®Google Scholar
• CaiZZhaoBRatkaAOxidative stress and β-amyloid protein in Alzheimer’s diseaseNeuromolecular Med20111322325021901428
   PubMed Web of Science ®Google Scholar
• KlugmanANaughtonDPIsaacMShahIPetrocziATabetNAntioxidant enzymatic activities in Alzheimer’s disease: the relationship to acetylcholinesterase inhibitorsJ Alzheimers Dis20123046747422451323
   PubMed Web of Science ®Google Scholar
• ManolopoulosKNKlotzLOKorstenPBornsteinSRBarthelALinking Alzheimer’s disease to insulin resistance: the FoxO response to oxidative stressMol Psychiatry2010151046105220966918
   PubMed Web of Science ®Google Scholar
• World Medical Association [homepage on the Internet]Ferney-Voltaire, FranceWorld Medical Association, Inc2014 Available from: http://www.wma.net/enAccessed March 1, 2014
   Google Scholar
• European Medicines Agency [homepage on the Internet]London, UKEuropean Medicines Agency2014 Available from: http://www.ema.europa.euAccessed March 1, 2014
   Google Scholar
• STROBE StatementStrengthening the Reporting of Observational Studies in EpidemiologyBern, SwitzerlandUniversity of Bern, Institute of Social and Preventive Medicine2009 Available from: http://www.strobe-statement.orgAccessed March 1, 2014
   Google Scholar
• National Institute for Health and Care ExcellenceLondon, UKNational Institute for Health and Care Excellence2014 Available from: http://www.nice.org.ukAccessed March 1, 2014
   Google Scholar
• FolsteinMFolsteinSMcHughPRMinimental state: a practical method for grading the cognitive state of patients for the clinicianJ Psychiatr Res1975121891981202204
   PubMed Web of Science ®Google Scholar
• RosenWGMohsRCDavisKLA new rating scale for Alzheimer’s diseaseAm J Psychiatry1984141135613646496779
   PubMed Web of Science ®Google Scholar
• HughesCPBergLDanzigerWLCobenLAMartinRLA new clinical scale for the staging of dementiaBr J Psychiatry19821405665727104545
   PubMed Web of Science ®Google Scholar
• MorrisJCThe Clinical Dementia Rating (CDR): current version and scoring rulesNeurology199343241224148232972
   PubMed Web of Science ®Google Scholar
• SeripaDFranceschiMD’OnofrioGPolymorphism C in the serotonin transporter gene (SLC6A4) in questionable dementia and Alzheimer’s diseaseNeurosci Lett200843833533918490109
   PubMed Web of Science ®Google Scholar
• PetersenRCDoodyRKurzACurrent concepts in mild cognitive impairmentArch Neurol2001581985199211735772
   PubMed Web of Science ®Google Scholar
• McKhannGDrachmanDFolsteinMKatzmanRPriceDStadlanEMClinical diagnosis of Alzheimer Disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Service Task Force on Alzheimer’s DiseaseNeurology1984349399446610841
   PubMed Web of Science ®Google Scholar
• RománGCTatemichiTKErkinjunttiTVascular dementia: diagnostic criteria for research studies Report of the NINDS-AIREN International WorkshopNeurology1993432502608094895
   PubMed Web of Science ®Google Scholar
• HachinskiVCIliffLDZilhkaECerebral blood flow in dementiaArch Neurol1975326326371164215
   PubMed Web of Science ®Google Scholar
• KatzSFordABMoskowitzRWJacksonBAJaffeMWStudies of illness in the aged: the index of ADL – a standardized measure of biological and psychological functionJAMA196318591491914044222
   PubMed Web of Science ®Google Scholar
• LawtonMPBrodyEMAssessment of older people: self-maintaining and instrumental activities of daily livingGerontologist196991791865349366
   PubMed Web of Science ®Google Scholar
• MillerSADykesDDPoleskyHFA simple salting out procedure for extracting DNA from human nucleated cellsNucleic Acids Res19981612153344216
   PubMed Web of Science ®Google Scholar
• Database of single nucleotide polymorphisms (dbSNPs) [database on the Internet]Bethesda, MDNational Center for Biotechnology Information2009 Available from: http://www.ncbi.nlm.nih.gov/snpAccessed March 1, 2014
   Google Scholar
• SeripaDSignoriEGravinaCMateraMGRinaldiMFazioVMSimple and effective determination of apolipoprotein E genotypes by positive/negative polymerase chain reaction productsDiagn Mol Pathol20061518018516932075
   PubMedGoogle Scholar
• WiggintonJECutlerDJAbecasisGRA note on exact tests of Hardy-Weinberg equilibriumAm J Hum Genet20057688789315789306
   PubMed Web of Science ®Google Scholar
• BarrettJCFryBMallerJDalyMJHaploview: analysis and visualization of LD and haplotype mapsBioinformatics20052126326515297300
   PubMed Web of Science ®Google Scholar
• GuanZZCross-talk between oxidative stress and modifications of cholinergic and glutaminergic receptors in the pathogenesis of Alzheimer’s diseaseActa Pharmacol Sin20082977378018565274
   PubMed Web of Science ®Google Scholar
• KrishnaswamyACooperEReactive oxygen species inactivate neuronal nicotinic acetylcholine receptors through a highly conserved cysteine near the intracellular mouth of the channel: implications for diseases that involve oxidative stressJ Physiol2012590pt 1394721969449
   PubMed Web of Science ®Google Scholar
• HagaSBBurkeWUsing pharmacogenetics to improve drug safety and efficacyJAMA2004291232869287115199039
   PubMed Web of Science ®Google Scholar
• GrossDNWanMBirnbaumMJThe role of FOXO in the regulation of metabolismCurr Diab Rep2009920821419490822
   PubMed Web of Science ®Google Scholar
• HansenRAGartlehnerGLohrKNKauferDIFunctional outcomes of drug treatment in Alzheimer‘s disease: A systematic review and meta-analysisDrugs Aging20072415516717313203
   PubMed Web of Science ®Google Scholar
• BizzarroAMarraCAcciarriAApolipoprotein E ε4 allele differentiates the clinical response to donepezil in Alzheimer’s diseaseDement Geriatr Cogn Disord20052025426116103669
   PubMed Web of Science ®Google Scholar
• ChoiSHKimSYNaHREffect of ApoE genotype on response to donepezil in patients with Alzheimer’s diseaseDement Geriatr Cogn Disord20082544545018401173
   PubMed Web of Science ®Google Scholar
• RigaudASTraykovLLatourFPresence or absence of at least one ε4 allele and gender are not predictive for the response to donepezil treatment in Alzheimer’s diseasePharmacogenetics20021241542012142731
   PubMedGoogle Scholar
• SantoroASivieroPMinicuciNEffects of donepezil, galantamine and rivastigmine in 938 Italian patients with Alzheimer’s disease: a prospective, observational studyCNS Drugs20102416317620088621
   PubMed Web of Science ®Google Scholar